Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2407
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer ; volume:21 ; number:1 ; day:23 ; month:7 ; year:2021 ; pages:1-9 ; date:12.2021
BMC cancer ; 21, Heft 1 (23.7.2021), 1-9, 12.2021

Creator
Chen, Jiayuan
Hua, Qingling
Wang, Haihong
Zhang, Dejun
Zhao, Lei
Yu, Dandan
Pi, Guoliang
Zhang, Tao
Lin, Zhenyu
Contributor
SpringerLink (Online service)

DOI
10.1186/s12885-021-08605-x
URN
urn:nbn:de:101:1-2021102400481895400907
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Chen, Jiayuan
  • Hua, Qingling
  • Wang, Haihong
  • Zhang, Dejun
  • Zhao, Lei
  • Yu, Dandan
  • Pi, Guoliang
  • Zhang, Tao
  • Lin, Zhenyu
  • SpringerLink (Online service)

Other Objects (12)

Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study

Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study

Pankreaskarzinom nab-Paclitaxel

Pankreaskarzinom nab-Paclitaxel

Breast cancer nab-Paclitaxel

Breast cancer nab-Paclitaxel

Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer

Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer

Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

Monitoring the progression of atherosclerotic plaque and disruption with contrast-enhancement MR imaging: an experimental study

Monitoring the progression of atherosclerotic plaque and disruption with contrast-enhancement MR imaging: an experimental study

Multiphasic Membranes/Scaffolds for Periodontal Guided Tissue Regeneration

Multiphasic Membranes/Scaffolds for Periodontal Guided Tissue Regeneration

Adaptive and nonadaptive samples in solving stochastic linear programs

Adaptive and nonadaptive samples in solving stochastic linear programs

A improved pooling method for convolutional neural networks

A improved pooling method for convolutional neural networks

Bureaucratic control across enterprise boundaries: labor organization and the control of the online car-hailing platforms

Bureaucratic control across enterprise boundaries: labor organization and the control of the online car-hailing platforms

Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine

Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine

Related objects